Estudo piloto de validação de um chatbot de rastreamento, implementado para direcionar a teleassistência em Covid-19

The novel coronavirus pandemic has overloaded healthcare systems to the limit. Our aim was to assess the effectiveness of a chatbot to identify symptoms of COVID-19. The chatbot was developed to screen patients before teleconsultation. The symptoms informed in the dialogue were compared with those r...

Descripción completa

Detalles Bibliográficos
Autores: Gabriel Fuly Cateb, Samuel Rosa Silveira Amaral, Samuel Cristovão Lopes Gonçalves, Isaias José Ramos de Oliveira, Raquel Oliveira Prates, Bruno Azevedo Chagas, Milena Soriano Marcolino, Zilma Silveira Nogueira Reis
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:Brasil
Institución:Universidade Federal de Minas Gerais (UFMG)
Repositorio:Repositório Institucional da UFMG
Idioma:portugués
OAI Identifier:oai:repositorio.ufmg.br:1843/60587
Acceso en línea:https://doi.org/10.34117/bjdv8n2-288
http://hdl.handle.net/1843/60587
https://orcid.org/0000-0001-9232-4309
https://orcid.org/0000-0002-7128-4974
https://orcid.org/0000-0002-8571-3135
https://orcid.org/0000-0003-4278-3771
https://orcid.org/0000-0001-6374-9295
Access Level:acceso abierto
Palabra clave:Chatbot
Covid-19
Telessaúde
Teleassistência
Piloto
Inteligência artificial
COVID-19
Telemedicina
Descripción
Sumario:The novel coronavirus pandemic has overloaded healthcare systems to the limit. Our aim was to assess the effectiveness of a chatbot to identify symptoms of COVID-19. The chatbot was developed to screen patients before teleconsultation. The symptoms informed in the dialogue were compared with those reported to the doctors in an emergency service. Among 96 patients assessed, dyspnea was the most frequent symptom (16,6%), and the only one that showed moderate agreement with the medical history recorded in electronic medical records (Kappa=0.605). In conclusion, the technology was useful in detecting one of the major symptoms of COVID-19. However, it was not possible to evidence its effectiveness to assessminor symptoms.